Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit.
Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit.
复制标题
DOI:
10.1038/s41598-020-76785-w
复制
发表时间:
2020-11-26
影响因子:
4.6
通讯作者:
University of Kentucky CRRT Quality Assurance Group
中科院分区:
文献类型:
--
作者:
Ruiz EF;Ortiz-Soriano VM;Talbott M;Klein BA;Thompson Bastin ML;Mayer KP;Price EB;Dorfman R;Adams BN;Fryman L;Neyra JA;University of Kentucky CRRT Quality Assurance Group
Critically ill patients with requirement of continuous renal replacement therapy (CRRT) represent a growing intensive care unit (ICU) population. Optimal CRRT delivery demands continuous communication between stakeholders, iterative adjustment of therapy, and quality assurance systems. This Quality Improvement (QI) study reports the development, implementation and outcomes of a quality assurance system to support the provision of CRRT in the ICU. This study was carried out at the University of Kentucky Medical Center between September 2016 and June 2019. We implemented a quality assurance system using a step-wise approach based on the (a) assembly of a multidisciplinary team, (b) standardization of the CRRT protocol, (c) creation of electronic CRRT flowsheets, (d) selection, monitoring and reporting of quality metrics of CRRT deliverables, and (e) enhancement of education. We examined 34-month data comprising 1185 adult patients on CRRT (~ 7420 patient-days of CRRT) and tracked selected QI outcomes/metrics of CRRT delivery. As a result of the QI interventions, we increased the number of multidisciplinary experts in the CRRT team and ensured a continuum of education to health care professionals. We maximized to 100% the use of continuous veno-venous hemodiafiltration and doubled the percentage of patients using regional citrate anticoagulation. The delivered CRRT effluent dose (~ 30 ml/kg/h) and the delivered/prescribed effluent dose ratio (~ 0.89) remained stable within the study period. The average filter life increased from 26 to 31 h (p = 0.020), reducing the mean utilization of filters per patient from 3.56 to 2.67 (p = 0.054) despite similar CRRT duration and mortality rates. The number of CRRT access alarms per treatment day was reduced by 43%. The improvement in filter utilization translated into ~ 20,000 USD gross savings in filter cost per 100-patient receiving CRRT. We satisfactorily developed and implemented a quality assurance system for the provision of CRRT in the ICU that enabled sustainable tracking of CRRT deliverables and reduced filter resource utilization at our institution.
登录
查看更多内容
影响因子:
1.6
作者:
Graham, Patricia;Lischer, Eileen
通讯作者:
Lischer, Eileen
DOI:
10.2215/cjn.00710113
发表时间:
2013-09-06
影响因子:
9.8
作者:
Susantitaphong, Paweena;Cruz, Dinna N.;Jaber, Bertrand L.
通讯作者:
Jaber, Bertrand L.
影响因子:
3
作者:
Bagshaw, Sean M.;Chakravarthi, Madarasu Rajasekara;Ronco, Claudio
通讯作者:
Ronco, Claudio
影响因子:
15.1
作者:
Oh, Hyung Jung;Lee, Mi Jung;Yoo, Tae-Hyun
通讯作者:
Yoo, Tae-Hyun
影响因子:
2.3
作者:
Brain M;Winson E;Roodenburg O;McNeil J
通讯作者:
McNeil J